Profound Medical Corp. (PROF)
NASDAQ: PROF
· Real-Time Price · USD
4.33
-1.21 (-21.84%)
At close: Aug 15, 2025, 3:59 PM
4.37
0.92%
After-hours: Aug 15, 2025, 05:13 PM EDT
Profound Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.72M | -5.33M | -9.44M | -6.92M | -6.58M | -8.91M | -5.56M | -7.36M | -6.74M | -9.53M | -5M | -5.93M | -8.21M | -10.16M | -6M | -7.04M | -7.5M |
Depreciation & Amortization | 163K | 76K | 268K | 287K | 305K | 299K | 287K | 277K | 283K | 256K | 372K | 497K | 479K | 496K | 487K | 471K | 425K |
Stock-Based Compensation | 989K | 442K | 604K | 768K | 767K | 907K | 727K | 842K | 941K | 565K | 1.21M | 1.59M | 875K | 2.41M | 1.99M | 1.7M | 1.1M |
Other Working Capital | 844K | -1.77M | 345.46K | 93K | -642K | 488K | 55K | -454K | 611.91K | 10.9K | -1.65M | -184.43K | 44K | 92K | -1.2M | 268K | 908K |
Other Non-Cash Items | 39K | -60K | 126K | 188K | 1K | 477K | 179K | 82K | 244K | 2.99M | -79K | -280K | 22K | 327K | -55K | -62K | 215K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 353K | n/a | n/a | n/a | n/a | n/a | -110K | -34K | -128K | -21K |
Change in Working Capital | 1.25M | -766K | 1.66M | -674K | 28K | 209K | 33K | 682K | -550K | -905K | -2.26M | -1.45M | -1.02M | 1.98M | -1.42M | -956K | -488K |
Operating Cash Flow | -8.28M | -5.64M | -6.36M | -6.35M | -4.53M | -7.02M | -4.34M | -5.12M | -5.82M | -6.62M | -5.75M | -5.57M | -7.86M | -5.05M | -5.02M | -6.02M | -6.27M |
Capital Expenditures | n/a | n/a | 1.00 | -0.27 | -1.6 | 0.84 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -127K | -121K | -164K | -181K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 239K | n/a | n/a | n/a | n/a | n/a | -127K | -121K | -164K | -181K |
Debt Repayment | -290K | -523K | -592K | -676K | -696K | -495K | -157.25K | -239K | -279K | 7.16M | -79K | -80K | -81K | -100K | -89K | -92K | -105K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -290K | -2.99M | n/a | 1K | -1.86M | 4K | -31.75K | -98.04K | 3.18M | -149K | 168K | 89K | 6K | 12K | 5.72M | 533.35K | 1.63M |
Financial Cash Flow | -290K | 35.65M | -592K | -603K | 20.46M | -491K | -189K | -239K | 2.14M | 7.01M | 89K | 9K | -75K | -88K | 4.48M | 356K | 1.2M |
Net Cash Flow | -8.48M | 27.79M | -6.96M | -7.1M | 14.97M | -7.41M | -5.65M | -3.71M | -3.53M | 309K | -7.03M | -6.89M | -7.03M | -5.07M | -1.55M | -4.74M | -5.4M |
Free Cash Flow | -8.28M | -5.64M | -6.83M | -6.22M | -4.53M | -7.02M | -4.34M | -5.12M | -5.82M | -6.62M | -5.75M | -5.57M | -7.86M | -5.18M | -5.14M | -6.18M | -6.45M |